Medchem (P.R.), Inc. - Page 19




                                       - 19 -                                         
          nonwoven web.8  These two groups of equipment constituted all of            
          the manufacturing equipment necessary to perform the work in                
          phase 1 of the manufacturing process; as of the later date, all             
          of the manufacturing equipment related to phase 1 was located in            
          MedChem U.S.A.’s facility in Woburn.  By January 1, 1991,                   
          petitioners had also transferred certain raw material                       
          manufacturing functions into MedChem U.S.A.’s Woburn facility as            
          well.                                                                       
               The equipment used to perform the work in phase 2 of the               
          manufacturing process, i.e., processing bulk flour into finished            
          flour and finishing and packaging the nonwoven web, remained in             
          Alcon P.R.’s manufacturing facility in Humacao until early 1995             
          at which time it was shipped to the Woburn facility.  Alcon P.R.            
          continued in Puerto Rico until early 1995 to manufacture finished           
          Avitene from bulk flour and dry, sterilize, and package nonwoven            
          web under the terms of the processing agreement.  Alcon P.R. did            
          so using bulk flour and nonwoven web that had been manufactured             
          in Humacao during a buildup in 1989 and 1990; it did not use any            
          bulk flour or nonwoven web manufactured elsewhere.  When                    
          petitioners moved the bulk and nonwoven web equipment to MedChem            
          U.S.A.’s facility in 1990, Alcon P.R. planned to use the part of            

               8 On separate occasions, MedChem U.S.A. reported to the                
          Securities and Exchange Commission (SEC) that, as of Nov. 30,               
          1990, and as of Feb. 28, 1991, respectively, MedChem U.S.A. was             
          in the process of redesigning its Amvisc manufacturing facility             
          in Woburn in order to start manufacturing Avitene there.                    





Page:  Previous  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  Next

Last modified: May 25, 2011